without reviewing the wording of the current guidelines. The current wording of the Choosing Wisely Canada (CWC) Family Medicine guideline on screening mammography is actually, ''Don't routinely do screening mammography for average risk women aged 40e49. Individual assessment of each woman's preferences and risk should guide the discussion and decision regarding mammography screening in this age group.'' The term ''low risk'' was changed to ''average risk'' within weeks of the original release at the request of the Canadian Association of Radiologists to comply with evidence of risk of breast cancer. It is frustrating to see that the inaccurate wording of the first version has been perpetuated in the CARJ itself several years later. It can only be inferred that the erroneous and misleading wording of the original CWC document has had a lasting impact.
Also troubling, the rather impressive-appearing level of evidence (LOE) for the screening mammography section belies many problems with the quality of the evidence. LOE, after all, should include consideration of both study design and quality of evidence. For example, the early studies from the 1960s to the 1980s were superficially well designed, but the largest study designed to study 40-50-year-olds was contaminated by poor randomization and patient crossover from non-screening to screening limbs and was the only study that failed to show a mortality benefit as compared with seven other randomized controlled trials (RCT). This has been well-documented. The other studies were not designed to distinguish between 40e50 years and 50 years and older.
Moreover, in radiology, a field highly sensitive to advances in technology, the quality of a study from the 1960s is severely eroded by obsolete imaging, even if the study had been well-designed and executed. Imagine publishing a brand-new paper on driving safety recommendations based on RCT evidence from cars made in the 1960s. Yes, there are some truths which may have stood the test of time, but the technological advances in brakes, steering, airbags, and crash-worthiness, as well as seatbelt legislation would certainly render the study quality much lower than the study design alone would imply.
There will likely never be another RCT on screening mammography, as it will never again be ethical to randomize women to a non-screening limb. Given this limitation, study design alone suggests that only the studies from the pre-screening eradthe infancy of mammographydyield the highest LOE.
Those who are involved in breast care, however, know that there are many studies which demonstrate large benefits, albeit non-RCT design. For those in Canada, the Pan-Canadian study [2] da large review of Canadian screening programsdis pertinent to a Canadian genetic mix, Canadian health care access, and those women who actually accessed screening. This study demonstrated a very significant breast cancer mortality benefit across all age groups, including the 40-49-year-old group.
The Canadian Task Force admittedly based its recommendations on the US Preventive Services Task Force recommendations. The CWC guidelines, in turn, base their recommendations exclusively on the Canadian Task Force recommendations. We hope to see a stronger weighting of recent Canadian evidence in the upcoming updates to the Canadian Task Force on Preventive Health Care (CTFPHC) guidelines and we hope they can see their way to finding some independence from the American guideline.
Unfortunately, the Canadian Association of Radiologists' support of the CWC guidelines may undermine its own credibility and guidelines, and it is disheartening to see CARJ acknowledging not only the uncorrected version of the CWC screening mammography guidelines, but also perpetuating the idea of obsolete RCTs as the highest LOE. Study quality is affected by technology in radiology more than many other specialties. Task forces composed of nonradiologists have not, to date, understood the impact of obsolete technology on study quality. It is the responsibility of radiologists to correct these errors.
The Canadian Association of Radiologists and CARJ have an opportunity to educate and enlighten Canadian physicians. Let us not waste it by lending excessive credence to outdated poor-quality evidence. 
